Category Archives: oud

Oracle ‘OK To Buy’ In Slow Transition, Say Analysts

With some clarity from Oracle’s (ORCL) Q2 earnings beat but disappointing Q3 guidance, investors traded Oracle stock down as much as 6% Thursday to a nearly three-month low. In late-afternoon trading in the stock market today, Oracle was down 4.5%, near 37. Oracle stock is more than 20% off its all-time high 46.71, set last Christmas Eve. The database leader “is still searching for a breakout after prolonged low-single-digit revenue growth,” UBS

Tesla ‘Corrects’ Autopilot Critics; Mobileye Rises

Mobileye (MBLY) crumbled Wednesday after short seller Citron Research named the company its 2016 “short of the year.” But the driver-assistance technology developer’s shares are rallying in the stock market today after Tesla Motors (TSLA) said in a blog post that it will continue to use Mobileye’s vision chip as part of its Autopilot feature. Citron cited a Bloomberg article from Wednesday in which a car hacker called Mobileye’s technology

Gilead Buys Into Galapagos Drug That AbbVie Ditched

Big biotech Gilead Sciences (GILD) agreed to license an immunology drug from smaller counterpart Galapagos (GLPG) Thursday in a deal that could be worth more than $2 billion. Galapagos’ drug is filgotinib, which is due to start phase three trials in rheumatoid arthritis and Crohn’s disease next year. Gilead agreed to pay a $300 million license fee and buy $425 million in Galapagos stock upfront, and promised up to $1.35 billion in milestone